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INTRODUCTION
According to the 2014 patient survey by the Ministry of Health,
Labour and Welfare, there were estimated 144,900 hospitalized pa-
tients with cancer and 231,600 cancer outpatients in Japan on the
day of the survey, and these numbers are increasing each year (1).
In recent years, outpatient cancer chemotherapy has been imple-
mented not only for blood cancers, but also as adjuvant chemo-
therapy for advanced and recurrent cancer lesions, and surgery
cases.
Patients with cancer who are undergoing chemotherapy are at
risk for undernutrition associated with adverse events. However,
nutritional management cannot be implemented as continuously
for outpatients as it can be for hospitalized patients. According to
a follow-up survey of 1,545 patients with cancer, risk factors for
death within 2 months include metastasis, poor general health, ad-
vanced age, and severe undernutrition (2). It has also been reported
that weight loss is associated with poor prognosis for patients with
cancer who have undergone chemotherapy (3, 4).
In Japan, with the revision of medical fees in April 2016 (5), can-
cer was added to the target diseases for which nutritional dietary
guidance is offered by national registered dietitians, and funds for
outpatient nutritional dietary guidance were increased. Therefore,
it is important to design nutritional management systems for out-
patients with cancer.
If nutritional evaluation could be performed quickly for patients
with cancer who are undergoing outpatient chemotherapy, under-
nutrition could be detected early and appropriate nutritional in-
tervention could be performed on patients who required it. Simple
nutritional evaluation tools include the Short Nutritional Assess-
ment Questionnaire (SNAQ) developed in the Netherlands in 2005
and the Malnutrition Universal Screening Tool (MUST) proposed
by the British Association for Parenteral and Enteral Nutrition
(BAPEN). The validity of both the SNAQ (6) and the MUST (7)
has been verified. The MUST has items that are evaluated by a
health care provider, and the SNAQ is more suitable for evaluation
by patients themselves.
The SNAQ is a simple nutritional evaluation method that, among
15 items for hospitalized patients, has some items that are most
useful for outpatients’ weight loss, loss of appetite, and use of nu-
tritional supplements and/or tube feeding. We used the SNAQ to
evaluate the nutritional status of Japanese patients with cancer
who were undergoing outpatient chemotherapy. Miura et al. (8)
reported that about 20% of these outpatients needed nutritional
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intervention. However, it is unclear whether the SNAQ is useful
for the nutritional evaluation of patients with cancer who are un-
dergoing outpatient chemotherapy. Leistra et al. (9) reported va-
lidity of the revised SNAQ in which age and body mass index (BMI)
were added to the traditional SNAQ. The result showed that the
sensitivity of revised SNAQ was higher than the traditional SNAQ.
Therefore, this study investigated the relationship between the
SNAQ and Controlling Nutritional Status (CONUT) (10) as a bi-
onutritional assessment or between the revised SNAQ and CONUT
and examined the utility of the SNAQ and the revised SNAQ as the
primary screening tool for patients receiving outpatient chemo-
therapy.
In this study, we used CONUT as an indicator of bionutritional
assessment. CONUT is a scale for nutritional evaluation that scores
serum albumin level (ALB), total cholesterol (T-cho), and total lym-
phocyte count (TLC). CONUT has been reported as a useful nutri-
tional evaluation tool in a comparative examination with Subjective
Global Assessment (SGA) (11), and there have been several re-
ports of its clinical value (12-14).
If the relationship between CONUT values and SNAQ scores
or between CONUT values and the revised SNAQ scores is clari-
fied in various settings, simple nutritional evaluation using the
SNAQ or the revised SNAQ will become possible. Therefore, we
used the SNAQ and the revised SNAQ in which age and BMI were
added to the evaluation criteria, for the nutritional evaluation of
patients with cancer who were undergoing outpatient chemother-
apy and examined their utility in determining the risks of moderate
and severe undernutrition according to CONUT values.
MATERALS AND METHODS
The subjects of this study were patients with cancer who were
undergoing outpatient chemotherapy. The percentage of Japanese
patients with cancer suffering from undernutrition has been re-
ported as 16.3% by Miura et al. (8). Thus, with an estimated 16.3%
of patients with cancer suffering from undernutrition, and a 95%
confidence level at5%, we calculated the sample size from the
estimate equation of the ratio of the population to be 210. Consid-
ering the possibility of dropouts, we set the target sample size at
300. We requested cooperation from 300 patients who were under-
going outpatient chemotherapy between October 2015 and April
2016 in the Department of Chemotherapy, University Hospital,
Kyoto Prefectural University of Medicine, and out of 290 who
agreed to cooperate, we selected 229 as subjects after excluding
those with missing data.
The patients were administered the survey on SNAQ 4 items
while they were receiving infusion chemotherapy. In addition, we
obtained information on patient characteristics (sex, age, name of
the disease, Performance Status Scale by the Eastern Cooperative
Oncology Group [ECOG PS]), and body measurements [height
and weight]) and calculated the BMI as the weight in kilograms
divided by the square of the height in meters. We measured levels
of serum albumin, total cholesterol, and TLC calculated CONUT
values. For the evaluation of nutritional status, CONUT values of
0-1 were considered normal, values of 2-4 were considered to indi-
cate mild undernutrition, values of 5-8 were considered to indicate
moderate undernutrition, and values of 9-12 were considered to
indicate severe undernutrition (Table 1).
In the SNAQ questions, patients were asked whether they had
experienced any of the following : weight loss of 6 kg or more
within the previous 6 months (3 points), weight loss of 3 kg or more
within the previous 1 month (2 points), loss of appetite within the
previous 1 month (1 point), and use of nutritional supplements or
tube feeding within the previous 1 month (1 point). The maximum
total score was 7 points.
In the revised SNAQ (9), age and BMI were added to the tradi-
tional SNAQ score. Patients under 65 years of age with BMI less
than 18.5 and those aged 65 years or more with BMI less than 20
received an additional 3 points. Patients under 65 years of age with
BMI less than 18.5-20 and those aged 65 years or more with BMI
less than 20-22 received an additional 2 points. Thus, the maximum
total score was 10 points.
Patients were classified according to their nutritional status as
measured by the SNAQ and the revised SNAQ as follows : total
score of 0-1 indicates undernourished, 2 indicate moderately un-
dernourished, 3 or higher indicates severely undernourished.
Statistical analysis
We summarized patient characteristics.
We investigated the prediction ability and cutoff value utility of
the SNAQ and revised SNAQ scores in relation to the determina-
tion of moderate and severe undernourishment by CONUT. To
that end, we calculated the receiver operating characteristics
(ROC) curve. For determination of CONUT (moderate and se-
vere/normal and mild), to calculate the odds ratio for each 1 point
of increase in the revised SNAQ score, we performed a logistic
regression analysis with sex as the adjustment variable. For logistic
Table 1 Assessment of the screening tool for controlling nutritional status (CONUT)
Parameter Normal Mild Moderate Severe
Serum albumin (ALB) (g/dl) 3.50 3.49 -3.00 2.99 -2.50 2.5
ALB score 0 2 4 6
Total lymphocyte count (TLC) (/µl) 1600 1599-1200 1199-800 800
TLC score 0 1 2 3
Total cholesterol (T-cho) (mg/dl) 180 179-140 139-100 100
T-cho score 0 1 2 3
*Total CONUT score 0-1 2 -4 5 -8 9 -12
Dysnutritional states Normal Mild Moderate Severe
*CONUT score=ALB score+TLC score+T-cho score
Table 1 shows CONUT values. The COUNT value is calculated using ALB, TLC, and T-cho
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regression estimates, 95% confidence intervals were calculated.
The analytical software IBM SPSS Statistics Version 23 (IBM Corp.)
was used to for the analyses.
Ethical considerations
The patients were given an outline of the study and informed that
necessary information, such as blood test results, would be col-
lected from medical files and that personal information would be
protected. Signed informed consent to participate in the study
was then obtained. This study was approved by the medical ethics
review committees of Kyoto Prefectural University of Medicine
(approval number : ERB-E-292-2) and Kyoto Prefectural Univer-
sity (approval number : 117).
RESULTS
Patient characteristics
Patient characteristics are shown in Table 2. The mean age of
the patients was 66.810.2 years. Colorectal cancer was the most
common type of cancer, followed by malignant lymphoma and
breast cancer. Thirty - five of the 229 patients (15.3%) had a BMI
less than 18.5. Forty patients (17.5%) had serum albumin levels
less than 3.5 g/dL. On the basis of CONUT scores, 4 patients (1.7%)
were determined to have severe undernutrition and 20 patients
(8.7%) were determined to have moderate undernutrition.
Responses to SNAQ questions
Table 3 shows patients’ responses to SNAQ questions. Gradual
weight loss of 6 kg or more within the previous six months was
reported by 36 patients (15.7%), and rapid weight loss of 3 kg or
more within the previous 1 month was reported by 23 patients
(10.0%). Sixty- four patients (27.9%) reported that they had expe-
rienced loss of appetite within the previous month.
Nutritional evaluation using the SNAQ and the revised SNAQ
Table 4 shows Assessment of nutritional status according to
SNAQ and revised SNAQ. According to the SNAQ, 54 patients
(23.6%) were classified as moderately or severely undernourished.
According to the revised SNAQ, 121 patients (52.8%) were classi-
fied as moderately or severely undernourished.
ROC curves for SNAQ and revised SNAQ scores for CONUT values
Figure 1 shows the ROC curves of CONUT values, SNAQ scores,
and revised SNAQ scores. The cutoff value for SNAQ scores cor-
responding to moderate or severe undernutrition in CONUT values
was 0.5, with a sensitivity of 87.5%, a specificity of 65.9%, and an area
under the ROC curve of 0.806. The cutoff value of the revised
SNAQ score was 2.5, with a sensitivity of 91.7%, a specificity of
62.9%, and an area under the ROC curve of 0.815. With the SNAQ
score, the boundary to identify moderately and severely under-
nourished with CONUT value was identified as not undernour-
ished. In contrast, the revised SNAQ was able to identify the group
that was severely undernourished, and the area under the ROC
curve was large. Therefore, it can be concluded that the revised
SNAQ can predict the CONUT value better than the original
SNAQ.
Comparison of revised SNAQ scores and CONUT values by mul-
tiple logistic regression analysis
Table 5 shows multinomial logistic model describing the asso-
ciation between and SNAQ revised SNAQ. To investigate the rela-
tionship between the SNAQ, revised SNAQ scores and the CONUT
values, we performed a binary logistic regression analysis using
the SNAQ scores, revised SNAQ scores and two groups of CONUT
values as dependent variables. The results showed that the higher
Table 2 Basic characteristics of the subjects n=229
Sex
Male 110 (48.0)
Female 119 (52.0)
Age (years)
Age65 76 (33.2)
Age65 153 (66.8)
Disease of the subjects
Colorectal cancer 52 (22.7)
Malignant lymphoma 48 (21.0)
Breast cancer 45 (19.7)
Stomach cancer 21 ( 9.2)
Pancreas cancer 18 ( 7.9)
Rectal cancer 11 ( 4.8)
Cholangiocarcinoma 8 ( 3.5)
Multiple myeloma 7 ( 3.1)
Esophageal cancer 6 ( 2.6)
Gallbladder cancer 3 ( 1.3)
Small intestine cancer 2 ( 0.9)
Myelodysplastic syndrome 2 ( 0.9)
Primary macroglobulinemia 2 ( 0.9)
Liver cancer 1 ( 0.4)
Peritoneal pseudomyxoma 1 ( 0.4)
Gastrointestinal cancer of unknown primary 1 ( 0.4)
Castleman’s disease 1 ( 0.4)
ECOG-PS*
0 127 (55.5)
1 87 (38.0)
2 14 ( 6.1)
3 1 ( 0.4)
4 0 ( 0.0)
BMI categrory
BMI18.5 35 (15.3)
BMI=18.5 -25 156 (68.1)
BMI25.0 38 (16.6)
TLC900/µl 37 (16.2)
TP6.5 g/dL 113 (49.3)
ALB3.5 g/dL 40 (17.5)
T-cho140 mg/dL 30 (13.1)
CONUT score categrory
Severe (9) 4 ( 1.7)
Moderate (5 -8) 20 ( 8.7)
Mild (2 -4) 110 (48.0)
Normal (0 -1) 95 (41.5)
Data are presented as n (%)
*ECOG-PS : Performance Status Scale of Eastern Cooperative Oncol-
ogy Group
The percentage shows the number of patient characteristics.
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the SNAQ value, the more patients were identified as moderately
and severely undernourished according to CONUT scores (odds
ratio, 1.48 ; 95% confidence interval, 1.34-1.96).
DISCUSSION
We examined the validity of the SNAQ and the revised SNAQ for
patients with cancer who were undergoing outpatient chemother-
apy. In compared with the SNAQ, the results of the revised SNAQ
showed that the sensitivity, specificity, and area under the ROC
curve of the revised SNAQ scores to CONUT values were 91.7%,
62.9%, and 0.815, respectively. The group that was identified as
moderately or severely undernourished by CONUT values was
identified as severely undernourished by the revised SNAQ score,
thus demonstrating that this score could be useful for primary
nutritional screening.
In this study, although the sensitivity and specificity of the SNAQ
score for the group identified as moderately or severely under-
nourished by CONUT values were 87.5% and 65.9%, respectively,
the sensitivity and specificity of the revised SNAQ score were 91.7%
and 62.9%, respectively. Therefore, the revised SNAQ, with age and
BMI added as items, provided higher sensitivity than the original
SNAQ. These results were consistent with a previous study by
Leistra et al. (9) that examined the validity of the SNAQ in outpa-
tients. The study showed that the sensitivity and specificity of the
SNAQ (43% and 99%, respectively) increased to 95% and 99% with
the use of the revised SNAQ. BMI, which was added to the revised
SNAQ, is an easy and useful indicator to evaluate nutritional status.
Age is said to impact nutritional status, and with aging, changes
in digestion, absorption, and energy metabolism are said to lead to
undernutrition (15). Therefore, it appears that the addition of age
and BMI to the evaluation criteria increased the sensitivity of the
evaluation.
Kruizenga et al. (16) reported that patients identified as suffering
from undernutrition (with a SNAQ score of 3 points or higher) had
low serum albumin, BMI, grip strength, and quality of life (QOL).
Identification of undernutrition with the SNAQ can be an indicator
of the patient’s general condition and QOL.
To perform nutritional screening of all patients with cancer who
are undergoing outpatient chemotherapy, the evaluation must be
easily implemented and accurate. The SNAQ could be a practical
nutritional evaluation tool. In a large-scale survey, Kruizenga et al.
(17) reported that the departments with a high proportion of un-
dernourished patients were geriatrics, oncology, gastroenterology,
and internal medicine. Rojer et al. (18) evaluated the nutritional
status of four groups of subjects hospitalized middle-aged patients,
elderly outpatients, healthy elderly people, and healthy young
people based on a BMI of 18.5 or less, rate of weight loss, age-
corrected BMI, and lean body mass and showed that the results
were different for each group. We hope to develop a nutritional risk
score that is specialized for patients with cancer who are undergo-
ing outpatient chemotherapy by adding items such as type of can-
cer, department where the patient is treated, and symptoms, with
the aim of providing continuous nutritional evaluation and man-
agement.
A limitation of the present study was that the specificity of the
revised SNAQ was 62.9%. This may have been because nutritional
evaluation with the SNAQ for the chief complaint is not reflected
in CONUT values. However, this low specificity is unlikely to place
a burden on patients or affect costs.
Another limitation is that in the revised SNAQ, the proportion of
patients identified as severely undernourished was high, at 42.8%.
In the revised SNAQ, those who are under 65 years of age with
BMI less than 20 and those who are 65 years of age or older with
BMI of less than 22 are given an additional 3 points, which increases
Table 3 Assessment of nutritional status according to SNAQ item
n=229
Weight loss6 kg in the last months 36 (15.7)
Weight loss3 kg in the last month 23 (10.0)
Decreased appetite last month 64 (27.9)
Use of sip/tube feed last month 13 ( 5.7)
n (%)
The percentage shows the number of each item of SNAQ.
Table 4 Assessment of nutritional status according to SNAQ and
revised SNAQ n=229
SNAQ score
No undernourished (0 -1) 175 (76.4)
Moderate undernourished (2) 8 ( 3.5)
Severe undernourished (3) 46 (20.1)
Reviesd SNAQ score
No undernourished (0 -1) 108 (47.2)
Moderate undernourished (2) 23 (10.0)
Severe undernourished (3) 98 (42.8)
n (%)
The percentage shows the number of nutritional evaluation using the
SNAQ and the revised SNAQ.
Revised SNAQ score
SNAQ score 
1?Speciflcity
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en
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Figure 1 ROC curve of the SNAQ and revised SNAQ in the severely
malnourished patients against the objective standard of malnutrition
Area under the curve (AUC) of the SNAQ score (95%CI) : AUC=0.806,
CI=0.714-0.897
Area under the curve (AUC) of the revised SNAQ (95%CI) : AUC=0.815,
CI=0.726-0.904
Table 5 Multinomial logistic model describing the association be-
tween SNAQ and revised SNAQ n=229
Odds ratio (95%CI)
SNAQ (by 1 point) 1.09 (0.67 -1.77)
Revised SNAQ (by 1 point) 1.48 (1.34 -1.96)
Logistic regression analysis using the SNAQ scores and the revised
SNAQ score and two groups of CONUT values as dependent variables.
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the proportion of severely undernourished patients. Thus, the va-
lidity of the additional points must be examined.
And another limitation is that it is not considered the effects of
clinical department cancer type, severity of cancer or chemother-
apy regimen. Therefore, we need to improve accuracy as screening
by adding items such as clinical department, cancer type and che-
motherapy regimen to the score.
Finally, although the CONUT bionutritional indicator was useful
in identifying patients who were moderately or severely under-
nourished, it cannot identify mild undernutrition. If continuing to
undergo chemotherapy causes patients who have been identified
as being mildly undernourished to become moderately or severely
undernourished, early -stage nutritional intervention will be nec-
essary.
In conclusion, the results suggest that the revised SNAQ, which
can identify the risk of moderate and severe undernourishment in
patients with cancer who are undergoing outpatient chemotherapy
in Japan, could be a useful primary screening tool.
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